University of Arizona

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).

349 total trials 56 currently recruiting 213 completed early-phase tilt top decile by trial count

University of Arizona: 349 sponsored US clinical trials, 56 recruiting.

University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.

Top-decile sponsor footprint

University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

349 total, page 3 of 7

COMPLETED NA

Inspiratory Muscle Strength Training in Adults With Type 2 Diabetes

NCT05643768

COMPLETED Phase 2

The Effect of Prior Learning on Word Learning

NCT05921188

COMPLETED NA

Easy Peasy: Health Effects of Supplementation With Vegetables

NCT05869929

COMPLETED NA

Adaptive Stress Response: The Hot Yoga Study

NCT06395376

COMPLETED NA

Mentored Community Gardening for Individuals With Skin Cancer

NCT05648604

COMPLETED NA

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

NCT05270135

TERMINATED

Novel Thermal Imaging Technique for Breast Screening

NCT05650086

COMPLETED NA

Improving Hypertension Medication Adherence for Older Adults

NCT05610059

COMPLETED Phase 2

Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment

NCT05515952

COMPLETED NA

Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults

NCT05178381

COMPLETED Phase 3

Pac-12 Test of the Effectiveness of Bodies in Motion in Reducing Disordered Eating and Body Image Concerns

NCT05864287

COMPLETED NA

Symptom Management for Rural-Urban Cancer Survivors and Caregivers

NCT05360498

COMPLETED

Liquid Biopsy for Early Non-small Lung Cancer Detection

NCT05462795

COMPLETED NA

Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention

NCT05277831

COMPLETED NA

Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors

NCT05597228

COMPLETED NA

A Behavioral Intervention With Foster Families

NCT05405972

COMPLETED

Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona

NCT04799665

TERMINATED

Heart Transplantation Utilizing NRP DCD

NCT05243914

COMPLETED NA

Enhancing Emotional and Motivational Development to Support Well-being and Retention in Diverse University Students

NCT05294913

TERMINATED Phase 3

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

NCT04669288

COMPLETED NA

Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi)

NCT05226585

TERMINATED

All Inclusive Kodex - EPD Study

NCT05489445

COMPLETED NA

A Randomized Controlled Trial to Improve Mother-Infant Synchrony Among Women With Childhood Adversity

NCT04818112

TERMINATED Phase 2

Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)

NCT04169074

COMPLETED Early Phase 1

Immune Response to the COVID-19 Vaccine

NCT04936997

TERMINATED Early Phase 1

Nitrous Oxide for Pain Management During In-Office Gynecology Procedures

NCT06661005

COMPLETED Phase 2

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

NCT03847311

COMPLETED Phase 2

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

NCT04859660

COMPLETED NA

The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma

NCT04760405

TERMINATED NA

Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)

NCT04295720

COMPLETED NA

Green Light Therapy As a Non-Pharmacologic Intervention to Decrease Anxiety in Pregnant Women With Opioid Use Disorder

NCT04776616

COMPLETED NA

Real-Time Caffeine Optimization During Total Sleep Deprivation

NCT04399083

COMPLETED NA

Ureteral Jets and Patient Positioning Study

NCT04732403

COMPLETED NA

Treatment Comparison for Undergraduate College Students With Traumatic Brain Injury

NCT04628741

TERMINATED Phase 2

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

NCT04668209

COMPLETED Phase 2

Medications for Obstructive Sleep Apnea In Children With Down Syndrome

NCT04115878

COMPLETED NA

Enhancement of Hippocampal Plasticity Using Repetitive Transcranial Magnetic Stimulation

NCT03962959

COMPLETED NA

Home-based tDCS and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms

NCT04375072

TERMINATED NA

Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic

NCT04374786

COMPLETED Early Phase 1

Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

NCT04554732

COMPLETED NA

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

NCT04329533

TERMINATED NA

Cardioprotective Effects of Freeze Dried Grape Powder on Blood Pressure and Plasma Lipids/Lipoproteins

NCT03659695

COMPLETED NA

Effect of Lower Pneumoperitoneum Pressure During Laparoscopic and Robotic Hysterectomy

NCT04125173

COMPLETED NA

Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention

NCT03455530

COMPLETED NA

An Assessment of TLR4 and TOPK/PRPK Signaling in Sun Damaged Human Skin Acutely Exposed to Solar Simulated Light

NCT05398237

TERMINATED NA

Hidradenitis Suppurativa Written Action Plan

NCT04230291

COMPLETED NA

Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea

NCT04176042

TERMINATED NA

The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites

NCT03937765

TERMINATED NA

Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome

NCT03522974

COMPLETED NA

Community Health Workers and Teleaudiology as a Culturally-relevant Approach to Improving Access to Hearing Health Care

NCT03864003

← Previous Page 3 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 43
Phase 2 57
Phase 3 8
Phase 4 13

What is open in the University of Arizona pipeline

56 recruiting of 349 indexed (16% open); 213 completed (61%).

Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Arizona: open-pipeline peers nationwide

Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20%25% Total trials Recruiting share University of ArizonaMontefiore Medical CenterNational Institute of Mental Health (NIMH)Children's Oncology GroupOhio State University Comprehensive Cancer CenterECOG-ACRIN Cancer Research GroupGeorge Mason UniversityUniversity of California, San FranciscoNational Human Genome Research Institute (NHGRI)
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 349 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this University of Arizona page

349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.

  • 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Arizona pipeline card: 349 registered trials from official public datasets.Report a data error.